Does L-carnitine work?
Searched over 200M research papers
Research Analysis by Consensus
Consensus Meter
The Efficacy of L-Carnitine: A Comprehensive Review
L-Carnitine and Weight Management
L-carnitine supplementation has shown promising results in weight management, particularly in overweight and obese individuals. A meta-analysis of 43 randomized controlled trials (RCTs) revealed that L-carnitine significantly reduced weight, body mass index (BMI), and fat mass. However, it did not significantly affect body fat percentage or waist circumference. The anti-obesity effects were more pronounced when L-carnitine was combined with other lifestyle modifications, such as diet and exercise.
L-Carnitine and Lipid Profiles
L-carnitine also plays a crucial role in improving lipid profiles. A systematic review and meta-analysis of 55 RCTs found that L-carnitine supplementation significantly reduced total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). These effects were dose-dependent, with higher doses (>2 g/day) showing more significant improvements.
L-Carnitine and Hyperthyroidism
In the context of hyperthyroidism, L-carnitine has been found to be effective in both reversing and preventing symptoms. A double-blind, placebo-controlled trial demonstrated that L-carnitine supplementation improved symptoms and biochemical parameters related to hyperthyroidism, including bone mineral density. This suggests that L-carnitine can be a valuable adjunct therapy for managing hyperthyroidism-related symptoms.
L-Carnitine and Exercise Performance
L-carnitine has been shown to enhance exercise endurance by promoting muscle oxidative metabolism. In a study involving mice, L-carnitine administration increased maximum running time and reduced body fat. It also improved muscle glycogen content and enhanced fatty acid uptake and oxidative metabolism. These findings indicate that L-carnitine can improve endurance capacity by optimizing energy metabolism during exercise.
L-Carnitine and Insulin Resistance
L-carnitine has shown potential in treating insulin resistance (IR). A meta-analysis of RCTs indicated that L-carnitine significantly improved the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) scores, particularly with prolonged treatment durations. This suggests that L-carnitine can be an effective adjuvant therapy for managing insulin resistance.
L-Carnitine and Cancer-Related Fatigue
Despite its benefits in other areas, L-carnitine supplementation did not show significant improvements in managing fatigue among cancer patients. A phase III, double-blind, placebo-controlled trial found no significant difference in fatigue levels between the L-carnitine and placebo groups. This indicates that L-carnitine may not be effective for this specific condition.
L-Carnitine and Acute Lung Injury
L-carnitine has demonstrated protective effects against acute lung injury (ALI) induced by potassium dichromate in rats. The treatment increased antioxidant levels and reduced inflammation, suggesting that L-carnitine could be a promising therapeutic agent for ALI.
L-Carnitine and Cardiovascular Disease
L-carnitine has shown benefits in the secondary prevention of cardiovascular disease. A meta-analysis of 13 controlled trials revealed that L-carnitine supplementation significantly reduced all-cause mortality, ventricular arrhythmias, and angina in patients experiencing acute myocardial infarction. These findings support the use of L-carnitine as a beneficial supplement in cardiovascular health.
L-Carnitine and Testicular Toxicity
L-carnitine has protective effects against testicular toxicity induced by trazodone. In a study on male rats, L-carnitine improved sperm count and motility, reduced oxidative stress, and modulated inflammation and autophagy-related genes. This suggests that L-carnitine can mitigate the adverse effects of certain medications on reproductive health.
L-Carnitine and Hemodialysis Patients
In maintenance hemodialysis (MHD) patients, L-carnitine supplementation has been shown to suppress inflammation and improve nutritional status. A study found that L-carnitine treatment significantly decreased serum C-reactive protein levels and increased serum albumin, transferrin, and hemoglobin levels, as well as BMI. These findings indicate that L-carnitine can be beneficial for MHD patients by enhancing their overall health and nutritional status.
Conclusion
L-carnitine supplementation offers a range of benefits, including weight management, improved lipid profiles, enhanced exercise performance, and protective effects against various health conditions. However, its efficacy can vary depending on the specific health condition and individual patient characteristics. Further research is needed to fully understand the potential and limitations of L-carnitine in different therapeutic contexts.
Sources and full results
Most relevant research papers on this topic